Suppr超能文献

狼疮肾炎中肾组织 HLA-G 表达分析:一项初步研究。

Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study.

机构信息

1 Department of Medical Sciences, Section of Rheumatology, University of Ferrara, Italy.

2 Centre for Complement and Inflammation Research, Imperial College London, UK.

出版信息

Lupus. 2019 Aug;28(9):1091-1100. doi: 10.1177/0961203319860582. Epub 2019 Jul 10.

Abstract

BACKGROUND

The study aimed to investigate whether HLA-G antigen is expressed in the kidneys of patients affected by lupus nephritis (LN) and whether its detection in renal biopsies could be adopted as a marker of treatment response and prognosis.

METHODS

Thirty renal biopsies from patients with LN were selected and analyzed through immunohistochemistry. Laboratory and clinical data were retrospectively collected at baseline, 6 and 12 months and at the latest clinical appointment. A number of patients (63.3%) were treated with rituximab (RTX) +/- methylprednisolone in the induction phase. The expression of HLA-G in glomeruli, tubules and infiltrating cells was examined and compared between lupus patients who achieved either complete or partial renal response and those who did not respond to treatment.

RESULTS

HLA-G staining was observed in the glomeruli of 20 of 30 samples from patients with LN. The expression of the antigen was detected in podocytes, along glomerular capillary walls, on parietal glomerular epithelial cells and within the juxtaglomerular apparatus. Seventy per cent of patients whose glomeruli expressed HLA-G achieved partial or complete response at 6 months and 75% at the latest available follow up compared with 30% and 40%, respectively, of those who did not show any expression. The pattern of staining in tubules and infiltrating cells was highly variable precluding any clinical correlation.

CONCLUSION

This study demonstrates that HLA-G is expressed in renal tissue in LN. Our retrospective data suggest that its expression could correlate with response to treatment.

摘要

背景

本研究旨在探讨 HLA-G 抗原是否在狼疮肾炎 (LN) 患者的肾脏中表达,以及在肾活检中检测其是否可作为治疗反应和预后的标志物。

方法

选择 30 例 LN 患者的肾活检组织进行免疫组织化学分析。回顾性收集基线、6 个月和 12 个月及最近临床随访时的实验室和临床数据。部分患者(63.3%)在诱导期接受利妥昔单抗(RTX)+/-甲基强的松龙治疗。比较完全或部分肾脏反应患者与无反应患者的 HLA-G 在肾小球、肾小管和浸润细胞中的表达。

结果

在 30 例 LN 患者的 20 例样本中观察到 HLA-G 染色。抗原表达在足细胞、肾小球毛细血管壁、壁层肾小球上皮细胞和肾小球旁器中检测到。在 6 个月时有 70%的 HLA-G 表达的肾小球患者达到部分或完全缓解,而在最新的随访中有 75%达到缓解,而无表达的患者分别为 30%和 40%。肾小管和浸润细胞的染色模式差异很大,无法进行任何临床相关性分析。

结论

本研究表明 HLA-G 在 LN 的肾组织中表达。我们的回顾性数据表明,其表达可能与治疗反应相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76f/7611013/635fe764452c/EMS127225-f001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验